The 22q11.2 deletion syndrome is commonly diagnosed using fluorescence in situ hybridization (FISH) with commercial probes. The chromosomal breakpoints and deletion size are subsequently characterized by short tandem repeat (STR) segregation tests or by further FISH probes. Recently, a multiplex ligation‐dependent probe amplification (MLPA) single tube assay was developed to detect deletions of the 22q11.2 region and other chromosomal regions associated with DiGeorge/velocardiofacial syndrome. We have compared the results of these three techniques in a group of 30 patients affected with 22q11.2 deletion syndrome. MLPA correctly called all patients who had been previously diagnosed by FISH. The MLPA results were concordant in all patients with the STR analysis in respect to deletion size. Furthermore, this novel technique resolved seven cases that were undetermined by STR analysis. These results confirm the efficiency of MLPA as a rapid, reliable, economical, high‐throughput method for the diagnosis of 22q11.2 deletion syndrome.
We report on two abortuses with hydrocephalus due to congenital stenosis of the aqueduct of Silvius. The occurrence of this disorder in two siblings (a male and a female) with normal parents supports the autosomal recessive pattern of inheritance. Such a mechanism of inheritance should be taken into account when counselling families with congenital hydrocephaly due to aqueduct stenosis.
We report on six additional patients with macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC; MIM 602501) and review the literature. This syndrome is a multiple congenital anomalies/mental retardation and overgrowth disorder comprising macrocephaly, cutis marmorata, vascular marks of lip and/or philtrum, syndactyly, hemihypertrophy, CNS anomalies, and developmental delay. Based on the findings in our 6 patients and on 69 patients previously reported we listed the very frequent (observed in >75%), frequent (25-75%), and less frequent (>25%) components of the syndrome.
We report on two abortuses with hydrocephalus due to congenital stenosis of the aqueduct of Silvius. The occurrence of this disorder in two siblings (a male and a female) with normal parents supports the autosomal recessive pattern of inheritance. Such a mechanism of inheritance should be taken into account when counselling families with congenital hydrocephaly due to aqueduct stenosis.
Abstract We report on an infant girl with trisomy 13 resulting from an inherited 13–15 Robertsonian translocation identified in a family from a small Spanish village of only 2,100 inhabitants. Both parents and several other relatives had a balanced 13–15 translocation.
Pregnant, 22 years old, first pregnancy. After the combined first trimester screening and a risk for Trisomy 18 equal 1/110, with a normal translucency and PAPP-A and BHCG extraordinarily low, chorionic villus sampling is performed. The result was Trisomy 15 mosaicism, then, amniocentesis is performed at week 16, for possible placental mosaicism, and the karyotype was normal. In the ultrasound monitoring at week 20, a shortening of the long bones was observed, so that, array-CGH was performed, and the result was: arr 2p25.1p24.3 (from 9,658,053 to 12,302,924) x1, so that, the fetus showed a loss of 2.64 Mb on the short arm of chromosome 2. A search of the possible consequences of this deletion was performed and we did not find any case published. This deletion was considered as uncertain consequences, but possibly pathological, by the size and content in genes. The parents was informed and decided to continue with the pregnancy. During ultrasound monitoring, shortening of the long bones became 4 weeks less that we expected, and in the last weeks of gestation, the fetal weight was in 4 Percentile with normal Doppler study. The baby currently has 8 months old, and only shows a discreet microcephaly. Growth and height are adequate and has an appropriate psychomotor development. This case is interesting because the same gestation, join, placental mosaicism and a fetal genetic anomaly. The first cause growth defects in the fetus and low levels of BHCG and PAPP-A. It is well known that PAPP-A is related with the development of the long bones. Moreover, the fetus is a carrier of an anomaly in their genetic material, of uncertain significance, and not described so far, making it difficult to inform the parents, especially when ultrasound findings are inconclusive.